EMERGENT BIODEFENSE OPERATIONS LANSING LLC

CANTON, MASSACHUSETTS 020211409

$101.61M
Total Contract Value
7 awards
First Award
Dec 16, 2022
Last Award
Sep 5, 2025
Business Size
small
CAGE Code
81CF1

Contract Awards

2 awards found

75A50122C00047
Department of Health and Human Services
$17.10M
Sep 5, 2025

THE PURPOSE OF THIS MODIFICATION IS TO EXERCISE CLIN0004B IN THE AMOUNT OF $17,104,200 FOR 40,000 TREATMENT COURSES OF ORAL SUSPENSION TEMBEXA AND UPDATED ARTICLE B.2.2 OPTIONS, TABLE 5.

NAICS: 541714 - RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY)FY2025
75A50122C00047
Department of Health and Human Services
$67.40M
Sep 19, 2024

CHIMERIX INC: AR&D FOR SMALLPOX ANTIVIRAL

NAICS: 541714 - RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY)FY2024

Business Details

UEI
JLLWGQX6LNA5
CAGE Code
81CF1
Address
50 SHAWMUT RD
CANTON, MA 020211409
Congressional District
MA-08

Parent Company

EMERGENT BIODEFENSE OPERATIONS LANSING LLC

Data Source

This profile is based on federal contract award data from USAspending.gov.

View on USAspending.gov